Former FDA Commissioner Robert Califf said the Trump administration’s FDA has been driven by political goals upending business as usual.
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly.
At least that’s how Robert Califf, former commissioner of the Food and Drug … [3890 chars]
Source: STAT | Published: 2026-03-20T00:54:44Z
Credit: STAT
